Safety and Tolerability of Physcion in Healthy Volunteers in a Phase I Dose Escalating Clinical Pharmacology Study

被引：0
|
作者：
Tzeng, Tsang-Bin
Chang, Wei-Kuo
Huang, Tien-Yu
Wu, Pei-Tzu
Huang, Wen-Chuan
Lee, Catherine
Wu, Hsing-Hua
Lai, Henry
Chang, Yi-Wei
Lee, Ming-Chung
Kung, Li-Pin
Friedman, Hylar
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S572 / S572
页数：1
相关论文
共 50 条
  • [31] Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers
    Gavin Choy
    Rajashree Joshi-Hangal
    Aram Oganesian
    Gil Fine
    Scott Rasmussen
    Joanne Collier
    James Kissling
    Amarpal Sahai
    Mohammad Azab
    Sanjeev Redkar
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 183 - 190
  • [32] First-In-Human Study of Oral BI 1358894 in Healthy Male Volunteers: A Phase I Study to Investigate Safety and Tolerability
    Goettel, Markus
    Hoefler, Josef
    Fuertig, Rene
    Sharma, Vikas
    Goettel, Markus
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S289 - S290
  • [33] Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers
    Seitz, Lisa
    Jin, Lixia
    Leleti, Manmohan
    Ashok, Devika
    Jeffrey, Jenna
    Rieger, Aimee
    Tiessen, Renger G.
    Arold, Gerhard
    Tan, Joanne B. L.
    Powers, Jay P.
    Walters, Matthew J.
    Karakunnel, Joyson
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (04) : 711 - 721
  • [34] Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers
    Lisa Seitz
    Lixia Jin
    Manmohan Leleti
    Devika Ashok
    Jenna Jeffrey
    Aimee Rieger
    Renger G. Tiessen
    Gerhard Arold
    Joanne B. L. Tan
    Jay P. Powers
    Matthew J. Walters
    Joyson Karakunnel
    Investigational New Drugs, 2019, 37 : 711 - 721
  • [35] Safety and tolerability of escalating cannabinoid doses in healthy cats
    Kulpa, Justyna E.
    Paulionis, Lina J.
    Eglit, Graham M. L.
    Vaughn, Dana M.
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2021, 23 (12) : 1162 - 1175
  • [36] Multiple Rising Doses of Oral BI 1358894 in Healthy Male Volunteers: A Phase I Study to Investigate Safety and Tolerability
    Goettel, Markus
    Herich, Lena
    Wiebe, Sabrina
    Fuertig, Rene
    Sharma, Vikas
    Goettel, Markus
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S417 - S418
  • [37] A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers
    Feng Xiao
    Feng Zhang
    Ling-ling Zhang
    Wei Wei
    European Journal of Clinical Pharmacology, 2018, 74 : 69 - 77
  • [38] A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers
    Xiao, Feng
    Zhang, Feng
    Zhang, Ling-ling
    Wei, Wei
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (01) : 69 - 77
  • [39] Evaluation of safety, tolerability and pharmacokinetics of single escalating oral doses of DPC 333 in healthy volunteers.
    Benedek, IH
    Fossler, M
    Wetherington, J
    Mondick, J
    Davis, C
    Kornhauser, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P61 - P61
  • [40] Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial
    Zhou, Qiang
    Wang, Zhiqiang
    Wang, Heming
    Chen, Zhidong
    Li, Xiaoyi
    Dai, Xiangrong
    Zhang, Yong
    Yu, Xiaohui
    Zhou, Renpeng
    Hu, Wei
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (01) : 101 - 112
12345